We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+6.06%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.67B
AUM Growth
-$82.5M
(-4.7%)
Cap. Flow
-$148M
Cap. Flow
% of AUM
-8.88%
Top 10 Holdings %
Top 10 Hldgs %
45.8%
Holding
40
New
3
Increased
13
Reduced
11
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$47.4M |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$23.4M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
+$23.2M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$17.6M |
| 5 |
MGM Resorts International
MGM
|
+$15.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$77.4M |
| 2 |
Gilead Sciences
GILD
|
+$65.2M |
| 3 |
Labcorp
LH
|
+$57.2M |
| 4 |
Adient
ADNT
|
+$34.5M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.23% |
| 2 | Consumer Discretionary | 12.17% |
| 3 | Technology | 7.33% |
| 4 | Financials | 7.17% |
| 5 | Communication Services | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
VeriSign
VRSN
$26.1B
| $33.7M | 2.02% |
316,997
-80,039
| -20% | -$8.06M |
|
27
Molina Healthcare
MOH
$10.2B
| $28.4M | 1.7% |
413,347
+7,856
| +2% | +$511K |
|
28
Atara Biotherapeutics
ATRA
$74.4M
| $27.3M | 1.64% |
66,101
+5,133
| +8% | +$1.93M |
|
|
CTRA
29
DELISTED
Coterra Energy
CTRA
| $24.6M | 1.47% |
+919,090
| New | +$23.4M |
|
30
Chipotle Mexican Grill
CMG
$47.8B
| $17.2M | 1.03% |
2,785,800
+1,083,150
| +64% | +$7.3M |
|
|
PVG
31
DELISTED
PRETIUM RESOURCES INC.
PVG
| $15.3M | 0.92% |
1,651,328
| – | – |
|
32
Teva Pharmaceuticals
TEVA
$40.9B
| $13.2M | 0.79% |
750,000
| – | – |
|
|
IPXL
33
DELISTED
Impax Laboratories, Inc.
IPXL
| $12.2M | 0.73% |
602,456
-738,687
| -55% | -$14.1M |
|
34
Wave Life Sciences
WVE
$1.09B
| $6.33M | 0.38% |
+290,885
| New | +$5.85M |
|
|
35
Adient
ADNT
$1.63B
| – | – |
-527,133
| Closed | -$34.5M |
|
|
36
Gilead Sciences
GILD
$162B
| – | – |
-921,797
| Closed | -$65.2M |
|
|
37
Labcorp
LH
$25.5B
| – | – |
-432,264
| Closed | -$57.2M |
|
38
Regeneron Pharmaceuticals
REGN
$77.6B
| – | – |
-51,505
| Closed | -$25.3M |
|
|
MGP
39
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| – | – |
-500,000
| Closed | -$14.6M |
|
|
SHPG
40
DELISTED
Shire pic
SHPG
| – | – |
-468,130
| Closed | -$77.4M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q3 2017 Portfolio in Review
As of Q3 2017, Bridger Management held 40 positions worth $1.67B, down 4.7% from $1.75B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Bridger Management withdrew a net $148M in Q3 2017, closing 6 positions and reducing 11 holdings. Its most notable exit was Shire pic, an estimated $77.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 51% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Bridger Management opened a new position in Coterra Energy worth $24.6M.
- Bridger Management's largest Q3 2017 buy was Coterra Energy: 919,090 shares worth $24.6M.
- Bridger Management added most to Alexion Pharmaceuticals in Q3 2017, an estimated $47.4M increase.
- Bridger Management's biggest Q3 2017 reduction was Alnylam Pharmaceuticals, cutting an estimated $32M.
- Bridger Management fully exited Shire pic in Q3 2017, selling an estimated $77.4M.
- Bridger Management's ten largest holdings make up 46% of its $1.67B portfolio in Q3 2017.
- Bridger Management opened 3 new positions and closed 6 in Q3 2017.
- Bridger Management's portfolio value fell 4.7% quarter-over-quarter to $1.67B.
Based on Bridger Management's 13F filing for Q3 2017, filed 14 Nov 2017.